Yoshimi Matsumoto

1.6k total citations
67 papers, 1.3k citations indexed

About

Yoshimi Matsumoto is a scholar working on Molecular Medicine, Pharmacology and Surgery. According to data from OpenAlex, Yoshimi Matsumoto has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Medicine, 18 papers in Pharmacology and 17 papers in Surgery. Recurrent topics in Yoshimi Matsumoto's work include Antibiotic Resistance in Bacteria (25 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers) and Helicobacter pylori-related gastroenterology studies (13 papers). Yoshimi Matsumoto is often cited by papers focused on Antibiotic Resistance in Bacteria (25 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers) and Helicobacter pylori-related gastroenterology studies (13 papers). Yoshimi Matsumoto collaborates with scholars based in Japan, United States and Germany. Yoshimi Matsumoto's co-authors include Takuya Kamimura, Y Mine, Kunihiko Nishino, Fumiaki Ikeda, Matsuhisa Inoue, Akihito Yamaguchi, Yoshihiro Yokota, Shuichi Tawara, Satoru Matsumoto and Ryota Iino and has published in prestigious journals such as PLoS ONE, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Yoshimi Matsumoto

65 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshimi Matsumoto Japan 19 488 356 287 183 167 67 1.3k
Wolfgang Haas United States 26 202 0.4× 256 0.7× 564 2.0× 224 1.2× 356 2.1× 71 2.0k
Roy Cleeland United States 21 249 0.5× 307 0.9× 420 1.5× 112 0.6× 159 1.0× 66 1.2k
Alisa W. Serio United States 17 582 1.2× 369 1.0× 472 1.6× 82 0.4× 175 1.0× 38 1.4k
Katie J. Aldred United States 8 514 1.1× 343 1.0× 738 2.6× 240 1.3× 164 1.0× 11 1.3k
R. T. TESTA United States 20 502 1.0× 663 1.9× 544 1.9× 209 1.1× 219 1.3× 34 1.4k
Roger Léger United States 16 981 2.0× 443 1.2× 735 2.6× 253 1.4× 191 1.1× 19 1.6k
Mahesh Patel India 27 745 1.5× 990 2.8× 628 2.2× 369 2.0× 242 1.4× 100 2.2k
M. Hedberg Sweden 20 173 0.4× 135 0.4× 225 0.8× 249 1.4× 191 1.1× 34 1.2k
Pamela Hunter United States 13 277 0.6× 380 1.1× 292 1.0× 193 1.1× 168 1.0× 26 1.1k
Alfonso J. Alanis United States 5 196 0.4× 141 0.4× 345 1.2× 134 0.7× 116 0.7× 7 1.1k

Countries citing papers authored by Yoshimi Matsumoto

Since Specialization
Citations

This map shows the geographic impact of Yoshimi Matsumoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimi Matsumoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimi Matsumoto more than expected).

Fields of papers citing papers by Yoshimi Matsumoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshimi Matsumoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimi Matsumoto. The network helps show where Yoshimi Matsumoto may publish in the future.

Co-authorship network of co-authors of Yoshimi Matsumoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshimi Matsumoto. A scholar is included among the top collaborators of Yoshimi Matsumoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshimi Matsumoto. Yoshimi Matsumoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsumoto, Yoshimi, et al.. (2024). Changes in the expression of <i>mexB</i>, <i>mexY</i>, and <i>oprD</i> in clinical <i>Pseudomonas aeruginosa</i> isolates. Proceedings of the Japan Academy Series B. 100(1). 57–67. 3 indexed citations
2.
Matsumoto, Yoshimi, et al.. (2020). Direct antibiotic susceptibility testing of blood cultures of gram-negative bacilli using the Drug Susceptibility Testing Microfluidic (DSTM) device. Journal of Infection and Chemotherapy. 26(6). 554–562. 6 indexed citations
3.
Matsumoto, Yoshimi, et al.. (2019). Double vascular ring: a case report of double aortic arch and concurrent pulmonary artery sling. European Heart Journal - Case Reports. 3(2).
4.
Iino, Ryota, Shouichi Sakakihara, Yoshimi Matsumoto, & Kunihiko Nishino. (2015). Single-Cell Detection and Collection of Persister Bacteria in a Directly Accessible Femtoliter Droplet Array. Methods in molecular biology. 1333. 101–109. 2 indexed citations
5.
Fujita, Junso, Mika Hirose, Chioko Nagao, et al.. (2013). Expression, purification, crystallization and preliminary crystallographic study of FtsA from methicillin-resistantStaphylococcus aureus. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 69(8). 895–898. 1 indexed citations
6.
Matsumura, Yoshiaki, et al.. (2002). [Adult sacrococcygeal teratoma: a case report].. PubMed. 48(10). 599–601. 10 indexed citations
7.
Matsumoto, Yoshimi. (2001). Activity of Bicozamycin against Eseherichia coli O157 : H7 Producing Vero Toxins.. Nippon Saikingaku Zasshi. 56(2). 455–463. 3 indexed citations
8.
Yamamoto, Hirofumi, Ayako Nakamura, Kohji Kawabata, et al.. (2001). Orally active cephalosporins. Part 3: synthesis, structure–activity relationships and oral absorption of novel C-3 heteroarylmethylthio cephalosporins. Bioorganic & Medicinal Chemistry. 9(2). 465–475. 11 indexed citations
9.
Watanabe, Yuji, Kazuo Hatano, Yoshimi Matsumoto, et al.. (1999). In Vitro Antibacterial Activity of FK041, a New Orally Active Cephalosporin.. The Journal of Antibiotics. 52(7). 649–659. 9 indexed citations
10.
Matsumoto, Yoshimi, et al.. (1999). Antibacterial activity of cefixime against Salmonella typhi and applicability of Etest. Journal of Infection and Chemotherapy. 5(3). 176–179. 9 indexed citations
12.
Ishikawa, H., Yoshimi Matsumoto, Toshiaki Kamimura, et al.. (1999). FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities. European Journal of Pharmacology. 378(3). 299–310. 6 indexed citations
13.
Barrett, David A., et al.. (1999). Studies on Anti-Helicobacter pylori Agents. Part 1: Benzyloxyisoquinoline Derivatives. Bioorganic & Medicinal Chemistry. 7(11). 2647–2666. 20 indexed citations
14.
Barrett, David A., et al.. (1998). Discovery of a novel benzyloxyisoquinoline derivative with potent anti-Helicobacter pylori activity. Bioorganic & Medicinal Chemistry Letters. 8(14). 1897–1902. 2 indexed citations
15.
Matsumoto, Yoshimi, et al.. (1998). [Antimicrobial activity of ofloxacin against recent clinical isolates from otitis media and otitis externa].. PubMed. 51(9). 561–75. 3 indexed citations
16.
Barrett, David G., Akira Tanaka, Hiroshi Sasaki, et al.. (1997). Studies on β-lactam antibiotics. Synthesis and antibacterial activity of novel 1β-methylcarbapenems related to FR21818: 5-membered ring analogs. Bioorganic & Medicinal Chemistry Letters. 7(11). 1409–1414. 8 indexed citations
17.
MINE, YASUHIRO, Yuji Watanabe, Kazuo Hatano, et al.. (1993). Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.. The Journal of Antibiotics. 46(1). 99–119. 17 indexed citations
18.
Nishimura, Shintaro, Nobuyoshi Yasuda, Hiroshi Sasaki, et al.. (1990). Synthesis and .BETA.-lactamase inhibitory activity of 7.ALPHA.-hydroxyethyl cephem sulfone and sulfoxide derivatives.. The Journal of Antibiotics. 43(1). 114–117. 3 indexed citations
19.
Matsumoto, Yoshimi, et al.. (1984). Mechanism of action of the new orally active cephalosporin FK027.. The Journal of Antibiotics. 37(7). 790–796. 38 indexed citations
20.
Matsumoto, Yoshimi. (1970). Social Stress and Coronary Heart Disease in Japan: A Hypothesis. The Milbank Memorial Fund Quarterly. 48(1). 9–9. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026